AB0775 The Diagnostic Value of the Asas Recommendations for Early Referral of Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain: Table 1

Autor: Angelique E. A. M. Weel, L. Van Hoeven, P. D. M. de Buck, Yvonne Vergouwe, Jolanda J. Luime, J. M. W. Hazes, K. H. Han
Rok vydání: 2015
Předmět:
Zdroj: Annals of the Rheumatic Diseases. 74:1158.1-1158
ISSN: 1468-2060
0003-4967
DOI: 10.1136/annrheumdis-2015-eular.2979
Popis: Background There is a delay between the onset of the first back pain symptoms and the final diagnosis of axial spondyloarthritis (axSpA). This delay can be explained by difficulties for primary care physicians to recognize and subsequently refer potential axSpA patients in the huge number of chronic low back pain (CLBP) patients seen in primary care. At this moment there is no widely accepted referral strategy. Recently the ASAS workgroup proposed recommendations for early referral although these were not yet validated in a primary care setting. Objectives To test the ASAS proposed recommendations for early referral in a primary care setting. Methods Our study population included primary care patients (18-45 years) with CLBP (≥3 months, age at back pain onset Results In total 941 primary care CLBP patients participated (58% female, mean age 36.0 years), of those were 181 (19%) identified as axSpA, 54 of the 181 (30%) were newly diagnosed with ankylosing spondylitis. 773 (82%) patients had at least one parameter present and thus according to the recommendations should be referred to the rheumatologists. The sensitivity of the ASAS recommendation is 100% (181/181), the specificity 22% (168/760) and the positive predictive value 23% (181/773) (Table 1). Conclusions The ASAS recommendation for early referral has a perfect sensitivity in primary care CLBP population. However this comes at the cost of a low specificity, meaning that almost 80% of the referred patients will undergo unnecessary diagnostic work up. A more specific referral strategy will be needed in daily primary care. Acknowledgements An unrestricted research grant was provided by AbbVie. Disclosure of Interest None declared
Databáze: OpenAIRE